Buscar
Mostrando ítems 31-40 de 74
Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents
(PERGAMON-ELSEVIER SCIENCE LTD, 2010)
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thiazolylhydrazones. To optimize this series, a number of medicinal chemistry directions were explored and new thiazolylhydrazones ...
Integration of Ligand- and Target-Based Virtual Screening for the Discovery of Cruzain Inhibitors
(WILEY-BLACKWELL, 2011)
A myriad of methods are available for virtual screening of small organic compound databases. In this study we have successfully applied a quantitative model of consensus measurements, using a combination of 3D similarity ...
Integração de métodos in silico e in vitro para o planejamento de inibidores da enzima cruzaína
(Universidade Federal de São CarlosBRUFSCarPrograma de Pós-Graduação em Química - PPGQ, 2011-06-30)
Chagas disease, caused by the flagellate protozoan of the family Trypanosomatidae Trypanosoma cruzi, is endemic in Latin America. The available drugs are ineffective and cause severe side effects. Therefore, it is necessary ...
Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain
(Editions Scientifiques Elsevier, 2016)
Enhancement of cruzipain activity by quinoxaline derivatives: an attempt to explain it by molecular dynamics studies
(MDPI, 2019)
The design of cruzipain (CZP) inhibitors, a key protease in the life cycle of the Trypanosoma cruzi, the causative agent of Chagas disease, constitutes one of the strategies for the search of antichagasic agents. In this ...